Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Innovative therapies for systemic sclerosis.
Ong VH, Denton CP. Ong VH, et al. Curr Opin Rheumatol. 2010 May;22(3):264-72. doi: 10.1097/BOR.0b013e328337c3d6. Curr Opin Rheumatol. 2010. PMID: 20190640 Review.
Management of systemic sclerosis.
Ong VH, Brough G, Denton CP. Ong VH, et al. Clin Med (Lond). 2005 May-Jun;5(3):214-9. doi: 10.7861/clinmedicine.5-3-214. Clin Med (Lond). 2005. PMID: 16011210 Free PMC article. Review. No abstract available.
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis.
De Lauretis A, Sestini P, Pantelidis P, Hoyles R, Hansell DM, Goh NS, Zappala CJ, Visca D, Maher TM, Denton CP, Ong VH, Abraham DJ, Kelleher P, Hector L, Wells AU, Renzoni EA. De Lauretis A, et al. Among authors: ong vh. J Rheumatol. 2013 Apr;40(4):435-46. doi: 10.3899/jrheum.120725. Epub 2013 Feb 1. J Rheumatol. 2013. PMID: 23378460
Targeted therapies for systemic sclerosis.
Denton CP, Ong VH. Denton CP, et al. Among authors: ong vh. Nat Rev Rheumatol. 2013 Aug;9(8):451-64. doi: 10.1038/nrrheum.2013.46. Epub 2013 Apr 9. Nat Rev Rheumatol. 2013. PMID: 23567456 Review.
80 results